Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data

Added 138 days ago (11.02.2022)
Authors: Alice B Gottlieb; Atul Deodhar; Iain B Mcinnes; Xenofon Baraliakos; Kristian Reich; Stefan Schreiber; Weibin Bao; Kwaku Marfo; Hanno B Richards; Luminita Pricop; Abhijit Shete; Vivek Trivedi; Deborah Keefe; Charis C Papavassilis; Piotr Jagiello; Philemon Papanastasiou; Philip J Mease; Mark Lebwohl
Read article